UBS Downgrades Novartis To Neutral, Sees 'No Meaningful Earnings Growth Expected Before '18'

Concerns loom over the prospects of Novartis AG (ADR) (NYSE: NVS), with lack of visibility into Alcon and Entresto. UBS’ ...